BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30353331)

  • 1. Quantitative Analysis of Red Bone Marrow Microenvironment Cells in Patients with Chronic Myeloid Leukemia, Multiple Myeloma, and Chronic Lymphocytic Leukemia in the Dynamics of Chemotherapy.
    Dolgikh TY; Kachesov IV; Tornuev VV; Vinogradova EV; Krinitsyna YM
    Bull Exp Biol Med; 2018 Oct; 165(6):786-789. PubMed ID: 30353331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connection between Parameters of Erythron System and Myelofibrosis during Chronic Myeloleukemia, Multiply Mieloma, and Chronic Lymphatic Leukemia.
    Dolgikh TY; Sholenberg EV; Kachesov IV; Senchukova SR
    Bull Exp Biol Med; 2018 Jan; 164(3):382-385. PubMed ID: 29308562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific Features of Interactions between Megakaryocytic and Granulocytic Hematopoiesis Lineages and Myelofibrosis during the Acute Phase of Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
    Dolgikh TY; Senchukova SR; Vinogradova EV; Krinitsyna YM
    Bull Exp Biol Med; 2020 Apr; 168(6):734-738. PubMed ID: 32333309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Myelofibrosis in Chronic Myeloid Leukemia, Multiple Myeloma, and Chronic Lymphoid Leukemia during Various Phases of Diseases.
    Dolgikh TY; Domnikova NP; Tornuev YV; Vinogradova EV; Krinitsyna YM
    Bull Exp Biol Med; 2017 Feb; 162(4):483-487. PubMed ID: 28239786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple myeloma and chronic leukaemias in 2014: improved understanding of disease biology and treatment.
    San-Miguel JF; Kantarjian HM
    Nat Rev Clin Oncol; 2015 Feb; 12(2):71-2. PubMed ID: 25511190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunohistochemical staining pattern of Gab2 correlates with distinct stages of chronic myeloid leukemia.
    Aumann K; Lassmann S; Schöpflin A; May AM; Wöhrle FU; Zeiser R; Waller CF; Hauschke D; Werner M; Brummer T
    Hum Pathol; 2011 May; 42(5):719-26. PubMed ID: 21292300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of image analysis and immunostaining of bone marrow trephine biopsy specimens to quantify residual disease in patients with B-cell chronic lymphocytic leukemia.
    Gala JL; Guiot Y; Delannoy A; Scheiff JM; Philippe M; Martiat P
    Mod Pathol; 1999 Apr; 12(4):391-9. PubMed ID: 10229504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
    Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
    Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of chemotherapy on bone marrow in patients with chronic lymphocytic leukaemia.
    Lemancewicz D; Dziecioł J; Kłoczko J; Piszcz J
    Folia Morphol (Warsz); 2004 Nov; 63(4):485-9. PubMed ID: 15712148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.
    Frater JL; Tallman MS; Variakojis D; Druker BJ; Resta D; Riley MB; Hrisinko MA; Peterson LC
    Am J Clin Pathol; 2003 Jun; 119(6):833-41. PubMed ID: 12817431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tipifarnib and bortezomib are synergistic and overcome cell adhesion-mediated drug resistance in multiple myeloma and acute myeloid leukemia.
    Yanamandra N; Colaco NM; Parquet NA; Buzzeo RW; Boulware D; Wright G; Perez LE; Dalton WS; Beaupre DM
    Clin Cancer Res; 2006 Jan; 12(2):591-9. PubMed ID: 16428505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptase-positive mast cells accompany lymphocytic as well as lymphoplasmacytic lymphoma infiltrates in bone marrow trephine biopsies.
    Wilkins BS; Buchan SL; Webster J; Jones DB
    Histopathology; 2001 Aug; 39(2):150-5. PubMed ID: 11493331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy-related changes of CD20+ and CD45RO+ lymphocyte subsets in chronic myeloid leukemia (CML): an immunohistochemical and morphometric study on sequential trephine biopsies of the bone marrow.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Cvetanovska G; Blum N; Schaefer HE
    Mod Pathol; 2000 Aug; 13(8):888-96. PubMed ID: 10955456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal abnormalities in neoplastic bone marrow diseases.
    Dührsen U; Hossfeld DK
    Ann Hematol; 1996 Aug; 73(2):53-70. PubMed ID: 8774614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature.
    Abuelgasim KA; Rehan H; Alsubaie M; Al Atwi N; Al Balwi M; Alshieban S; Almughairi A
    J Med Case Rep; 2018 Mar; 12(1):64. PubMed ID: 29524963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemias and plasma cell myeloma.
    Wiernik PH
    Cancer Chemother Biol Response Modif; 1997; 17():390-407. PubMed ID: 9551222
    [No Abstract]   [Full Text] [Related]  

  • 17. Simultaneous occurrence of chronic lymphocytic and chronic myeloid leukemia.
    Katović SK; Vasilj A; Maricević I; Carzavec D; Jurić SC
    Coll Antropol; 2010 Jun; 34(2):653-5. PubMed ID: 20698147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemias and plasma cell myeloma.
    Wiernik PH
    Cancer Chemother Biol Response Modif; 1999; 18():268-92. PubMed ID: 10800488
    [No Abstract]   [Full Text] [Related]  

  • 19. A case report of chronic myelogenous leukemia in a patient with multiple myeloma and a review of the literature.
    Ragupathi L; Najfeld V; Chari A; Petersen B; Jagannath S; Mascarenhas J
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):175-9. PubMed ID: 23168212
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic myelogenous leukemia evolving after treatment of multiple myeloma.
    Wolleschak D; Heidel FH
    Blood; 2016 Jul; 128(1):146. PubMed ID: 28092869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.